Document Detail

Optimization of mid-dilution haemodiafiltration: technique and performance.
MedLine Citation:
PMID:  19420103     Owner:  NLM     Status:  MEDLINE    
BACKGROUND: Mid-dilution haemodiafiltration (MD-HDF), reported as a highly efficient convective-mixed technique, has demonstrated serious drawbacks in relation to the high pressure originating inside the blood compartment of the filter during clinical application. This randomized crossover design study was planned to optimize the efficiency of the MD-HDF technique while reducing its inherent risks. METHODS: Fifteen patients on RRT were submitted in random sequence to standard and reverse MD-HDF under similar operating conditions. Efficiency in solute removal was evaluated by measuring urea (U), phosphate (P) and beta2-microglobulin (beta2-m), mean dialysate clearances (K(DQ)) and eKt/V. Blood and dialysate compartment pressures were monitored on-line during the sessions, and instantaneous hydraulic and membrane permeability indexes were calculated. RESULTS: During standard MD-HDF sessions, unlike with reverse MD-HDF, excessive blood inlet and transmembrane pressure prevented the planned infusion from being maintained. Resistance index and membrane permeability to water and middle molecules substantially improved with reverse MD-HDF. This resulted in higher beta2-m removal (221.3 +/- 81.3 versus 185.1 +/- 65.5 mg/session, P = 0.007). Phosphate removal was comparable, while U removal was greater with standard MD-HDF (K(DQ) 272 +/- 35 versus 252 +/- 29 ml/min, P = 0.002; eKt/V 1.63 +/- 0.23 versus 1.49 +/- 0.17, P = 0.005). CONCLUSIONS: This study demonstrated the ability of MD-HDF to remove significant amounts of medium-sized uraemic compounds and phosphate, but safe rheologic and hydraulic conditions were only maintained by carrying out treatments with the dialyser used in reverse configuration. For this purpose, the larger MD-220 dialyser ensured better tolerance together with higher middle molecules clearance, even though small molecule removal was slightly worsened. The results of this study may provide some insight into the complex interactions between pressures and flux within the original structure of MD-dialysers and help optimize the clinical application of the technique and reduce its risks.
Luciano A Pedrini; Annalisa Feliciani; Simona Zerbi; Giorgio Cozzi; Pio Ruggiero
Related Documents :
16711933 - Ion energy distribution and gas heating in the cathode fall of a direct-current microdi...
17995833 - Evaluation of thermal properties of food materials at high pressures using a dual-needl...
2597573 - Development of a new circulatory assist method with the combined effects of intra-aorti...
Publication Detail:
Type:  Journal Article; Randomized Controlled Trial     Date:  2009-05-06
Journal Detail:
Title:  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association     Volume:  24     ISSN:  1460-2385     ISO Abbreviation:  Nephrol. Dial. Transplant.     Publication Date:  2009 Sep 
Date Detail:
Created Date:  2009-08-18     Completed Date:  2009-12-01     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8706402     Medline TA:  Nephrol Dial Transplant     Country:  England    
Other Details:
Languages:  eng     Pagination:  2816-24     Citation Subset:  IM    
Bolognini Hospital, Seriate, Bergamo, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Cross-Over Studies
Hemodiafiltration / instrumentation,  methods*
Middle Aged
Phosphates / blood,  isolation & purification
Prospective Studies
Toxins, Biological / blood,  isolation & purification
Urea / blood,  isolation & purification
beta 2-Microglobulin / blood,  isolation & purification
Reg. No./Substance:
0/Phosphates; 0/Toxins, Biological; 0/beta 2-Microglobulin; 0/uremia middle molecule toxins; 57-13-6/Urea

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Mechanical forces and TGF{beta}1 reduce podocyte adhesion through {alpha}3{beta}1 integrin downregul...
Next Document:  Interleukin-1 beta regulates proximal tubular cell transforming growth factor beta-1 signalling.